Vanguard Capital Management
CELU icon

Vanguard Capital Management’s Celularity CELU Stock Holding History

Vanguard Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Hold
621,105
– – ﹤0.01% 3757
2026
Q1 		$826K Buy
+621,105
New +$786K ﹤0.01% 3588

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Vanguard Capital Management's CELU Position: Q2 2026 in Review

Vanguard Capital Management held its Celularity (CELU) position steady in Q2 2026 at 621,105 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

Vanguard Capital Management first reported a position in CELU in Q1 2026 and has held it in 2 quarters since. The position peaked at $826K in Q1 2026. 40 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Vanguard Capital Management held 621,105 shares of Celularity worth $371K as of Q2 2026.
  • Vanguard Capital Management left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3757 holding.
  • Vanguard Capital Management first reported a position in Celularity in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Celularity position peaked at $826K in Q1 2026.
  • 40 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.